$2.69
At close: Jun 26, 12:24 PM EDT
$4.50
1.8167.29%
After Hours: Dec 19, 4:00 PM EDT
Comments
Loading...
Relief Therapeutics Analyst Ratings and Price Targets | OTC:RLFTF | Benzinga
Relief Therapeutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Relief Therapeutics Corp from these most-recent analyst ratings.
Analyst Ratings for Relief Therapeutics
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Relief Therapeutics (RLFTF) stock?
There is no price target for Relief Therapeutics
What is the most recent analyst rating for Relief Therapeutics (RLFTF)?
There is no analyst for Relief Therapeutics
When was the last upgrade for Relief Therapeutics (RLFTF)?
There is no last upgrade for Relief Therapeutics
When was the last downgrade for Relief Therapeutics (RLFTF)?
There is no last downgrade for Relief Therapeutics.
When is the next analyst rating going to be posted or updated for Relief Therapeutics (RLFTF)?
There is no next analyst rating for Relief Therapeutics.
Is the Analyst Rating Relief Therapeutics (RLFTF) correct?
There is no next analyst rating for Relief Therapeutics.
Browse analyst ratings and price targets on all stocks.
